Completed NA INTERVENTIONAL 1-arm NCT03106194

Case Management in HCV Infected PWID (CM-HCV)

Case Management in Hepatitis C Virus Infected People Who Inject Drugs in Belgium

Sponsor: CAD Limburg

Updated 7 times since 2017 Last updated: Jan 23, 2020 Started: Jul 31, 2016 Primary completion: Nov 30, 2018 Completion: Nov 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Drug Abuse, Intravenous and is currently completed. CAD Limburg leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Feb 2020 — Jan 2021 [monthly]

Completed NA

Status: Unknown Status → Completed
May 2019 — Feb 2020 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Jun 2018 — May 2019 [monthly]

Recruiting NA
May 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Jul 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CAD Limburg
Hasselt University
Ziekenhuis Oost-Limburg

Data source: Hasselt University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Genk, Belgium